SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

Balance Sheet

Inspect the capital base behind the business.

Assets

$115.87M

FY 2025 · Annual

Liabilities

$214.70M

FY 2025 · Annual

Equity

-$98.84M

FY 2025 · Annual

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$238.9M
Short-term Investments$12.1M
Receivables$653.0K
Other Current$1.7M
Total Current Assets$253.4M
PP&E (Net)$4.2M
Other Non-current$789.0K
Total Non-current Assets$5.0M
Total Assets$258.4M

Analysis

Selected assets total $258.4M for Latest. The largest visible component is Cash & Equivalents at $238.9M, about 92.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportOct 19, 2026
8-KCurrent reportOct 1, 2026
10-QQuarterly reportAug 6, 2026

How much cash does SGP have?

SpyGlass Pharma, Inc. Common Stock (SGP) reported $96.36M in cash and equivalents in fiscal 2025.

How much debt does SGP carry?

SpyGlass Pharma, Inc. Common Stock (SGP) reported $1.58M of total debt, with net debt of -$94.78M.